RIM
IRWD icon

Redwood Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Redwood Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-534,560
Closed -$2.15M – 354
2024
Q3 		$2.15M Buy
534,560
+58,783
+12% +$316K 0.19% 100
2024
Q2 		$2.86M Buy
475,777
+109,086
+30% +$772K 0.25% 85
2024
Q1 		$3.19M Buy
366,691
+84,072
+30% +$1.02M 0.3% 79
2023
Q4 		$3.23M Sell
282,619
-47,188
-14% -$467K 0.3% 63
2023
Q3 		$3.18M Sell
329,807
-50,859
-13% -$498K 0.28% 88
2023
Q2 		$3.76M Buy
380,666
+47,572
+14% +$511K 0.39% 76
2023
Q1 		$3.5M Buy
333,094
+98,235
+42% +$1.1M 0.38% 79
2022
Q4 		$2.91M Sell
234,859
-10,387
-4% -$118K 0.39% 62
2022
Q3 		$2.54M Buy
245,246
+8,808
+4% +$99.9K 0.53% 33
2022
Q2 		$2.73M Buy
236,438
+12,186
+5% +$144K 0.46% 48
2022
Q1 		$2.82M Buy
224,252
+32,631
+17% +$374K 0.42% 67
2021
Q4 		$2.23M Buy
191,621
+34,546
+22% +$424K 0.29% 84
2021
Q3 		$2.05M Buy
157,075
+15,720
+11% +$203K 0.29% 73
2021
Q2 		$1.82M Buy
141,355
+9,190
+7% +$105K 0.3% 62
2021
Q1 		$1.48M Buy
132,165
+33,289
+34% +$352K 0.28% 65
2020
Q4 		$1.13M Sell
98,876
-26,564
-21% -$291K 0.19% 94
2020
Q3 		$1.13M Buy
125,440
+26,849
+27% +$267K 0.28% 74
2020
Q2 		$1.02M Buy
98,591
+18,654
+23% +$191K 0.29% 38
2020
Q1 		$807K Sell
79,937
-9,933
-11% -$117K 0.51% 40
2019
Q4 		$1.2M Sell
89,870
-33,292
-27% -$367K 0.3% 82
2019
Q3 		$1.06M Buy
123,162
+27,749
+29% +$270K 0.29% 77
2019
Q2 		$1.04M Buy
+95,413
New +$1.07M 0.29% 53

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Redwood Investment Management's IRWD Position: Q4 2024 in Review

Redwood Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2024, closing a stake of 534,560 shares — an estimated $2.15M sold.

Redwood Investment Management first reported a position in IRWD in Q2 2019 and held it in 22 quarters. The position peaked at $3.76M in Q2 2023. 223 funds tracked by Wall St. Rank hold IRWD as of Q4 2024.

  • Redwood Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Redwood Investment Management sold 534,560 Ironwood Pharmaceuticals shares in Q4 2024, an estimated $2.15M.
  • Redwood Investment Management first reported a position in Ironwood Pharmaceuticals in Q2 2019 and held it in 22 quarters.
  • Redwood Investment Management's Ironwood Pharmaceuticals position peaked at $3.76M in Q2 2023.
  • 223 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2024.

Based on Redwood Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.